Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology.

PubWeight™: 2.15‹?› | Rank: Top 2%

🔗 View Article (PMC 3716407)

Published in Neurology on May 28, 2013

Authors

Melissa J Armstrong1, Gary Gronseth, David C Anderson, José Biller, Brett Cucchiara, Rima Dafer, Larry B Goldstein, Michael Schneck, Steven R Messé

Author Affiliations

1: Department of Neurology, University of Maryland School of Medicine, Baltimore, USA.

Associated clinical trials:

Niacin Plus Statin to Prevent Vascular Events | NCT00120289

Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) | NCT00576693

Articles by these authors

High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 8.30

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.87

2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke (2015) 5.64

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 4.59

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke (2003) 4.13

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06

Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74

Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59

Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2013) 3.54

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation (2006) 2.86

Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66

Invited article: is it time for neurohospitalists? Neurology (2008) 2.65

American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation (2003) 2.49

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2006) 2.42

Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 2.37

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2010) 2.18

Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17

Low LDL cholesterol, statins, and brain hemorrhage: should we worry? Neurology (2007) 2.09

ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology (2014) 2.08

Predicting aspiration in patients with ischemic stroke: comparison of clinical signs and aerodynamic measures of voluntary cough. Chest (2008) 1.96

Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke (2011) 1.92

Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke (2005) 1.85

Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program. Stroke (2009) 1.78

Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke (2006) 1.76

Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. Stroke (2008) 1.70

Predictors of hospital readmission after stroke: a systematic review. Stroke (2010) 1.67

Still no closure on the question of PFO closure. N Engl J Med (2013) 1.64

Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2012) 1.62

Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 1.62

Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60

Seizures and epilepsy after ischemic stroke. Stroke (2004) 1.58

CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke (2007) 1.55

Interictal cortical hyperresponsiveness in migraine is directly related to the presence of aura. Cephalalgia (2013) 1.50

Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke (2002) 1.48

ACCF/AHA consensus conference report on professionalism and ethics. Circulation (2004) 1.47

Cough and aspiration of food and liquids due to oral-pharyngeal dysphagia: ACCP evidence-based clinical practice guidelines. Chest (2006) 1.46

Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke (2011) 1.45

Cost-effectiveness analysis of protected carotid artery stent placement versus endarterectomy in high-risk patients. J Endovasc Ther (2010) 1.45

Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology (2012) 1.43

The new standing guideline committee policy of the American Stroke Association Stroke Council. Stroke (2006) 1.42

Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med (2003) 1.41

Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41

Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke (2011) 1.39

How long are delays to carotid imaging and endarterectomy, and how do these delays affect recurrent stroke risk? Nat Clin Pract Neurol (2006) 1.38

Contrast-enhanced magnetic resonance angiography of carotid arteries: utility in routine clinical practice. Stroke (2002) 1.38

Free-floating thrombus of the carotid artery: literature review and case reports. J Vasc Surg (2007) 1.36

The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association. Circulation (2009) 1.33

Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32

Stroke rates: 1980-2000: the Minnesota Stroke Survey. Am J Epidemiol (2009) 1.31

30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals. Stroke (2011) 1.29

TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells. Blood (2009) 1.26

Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis. Stroke (2012) 1.26

Cervical arterial dissections and association with cervical manipulative therapy: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2014) 1.25

Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2007) 1.22

Preventable readmissions within 30 days of ischemic stroke among Medicare beneficiaries. Stroke (2013) 1.18

Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke (2009) 1.18

Medicine. Stroke--tPA and the clinic. Science (2003) 1.18

Cortical stimulation for the rehabilitation of patients with hemiparetic stroke: a multicenter feasibility study of safety and efficacy. J Neurosurg (2008) 1.18

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke (2009) 1.17

The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assembly. Cell (2011) 1.16

Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2008) 1.15

Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology (2004) 1.15

Utility of dysphagia screening results in predicting poststroke pneumonia. Stroke (2010) 1.13

ABC/XYZ estimates intracerebral hemorrhage volume as a percent of total brain volume in children. Stroke (2010) 1.13

Recurrent strokes in two patients with POEMS syndrome and Castleman's disease. J Stroke Cerebrovasc Dis (2007) 1.13

Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clin Neurol Neurosurg (2003) 1.08

American Academy of Neurology replies to Jeanne Lenzer. BMJ (2013) 1.07

Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol (2011) 1.07

JURaSSiC: accuracy of clinician vs risk score prediction of ischemic stroke outcomes. Neurology (2013) 1.07

Cerebral magnetic resonance findings in asymptomatic patients after atrial fibrillation catheter ablation: cause for alarm or further study? J Cardiovasc Electrophysiol (2011) 1.06

Imidacloprid induces neurobehavioral deficits and increases expression of glial fibrillary acidic protein in the motor cortex and hippocampus in offspring rats following in utero exposure. J Toxicol Environ Health A (2008) 1.06

Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05

Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci (2003) 1.05

Intravitreal ranibizumab and bevacizumab: a review of risk. Semin Ophthalmol (2007) 1.02

30-Day risk-standardized mortality and readmission rates after ischemic stroke in critical access hospitals. Stroke (2012) 1.02

Five-year rehospitalization outcomes in a cohort of patients with acute ischemic stroke: Medicare linkage study. Stroke (2011) 1.02

Safety of 6-Hz primed low-frequency rTMS in stroke. Neurorehabil Neural Repair (2007) 1.01

The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study. J Med Internet Res (2015) 1.01

Stroke: working toward a prioritized world agenda. Cerebrovasc Dis (2010) 1.01

"Code stroke": hospitalized versus emergency department patients. J Stroke Cerebrovasc Dis (2011) 1.01

Obstructive hydrocephalus from venous sinus thrombosis. Neurocrit Care (2009) 1.01

Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc Dis (2009) 0.99

Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain. Stroke (2010) 0.99

Recognition and management of stroke in young adults and adolescents. Neurology (2013) 0.98

Geographic variation in one-year recurrent ischemic stroke rates for elderly Medicare beneficiaries in the USA. Neuroepidemiology (2010) 0.98

Musical hallucinations and forgotten tunes - case report and brief literature review. Front Neurol (2013) 0.97

Depression and antidepressant use after stroke and transient ischemic attack. Stroke (2012) 0.97

Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. Int J Stroke (2011) 0.97

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. Am Heart J (2009) 0.97

Lost in a jungle of evidence: we need a compass. Neurology (2008) 0.96